Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Radical -xh acid – or anhydride – acid halide or salt thereof...
Reexamination Certificate
2002-04-12
2008-08-19
Kwon, Brian-Yong S (Department: 1614)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Radical -xh acid, or anhydride, acid halide or salt thereof...
C514S563000, C514S564000, C514S546000
Reexamination Certificate
active
07414077
ABSTRACT:
Methods are provided for promoting longevity and decreasing the incidence of ageing associated pathologies (e.g. cancer) by the administration of one or more of the following LFFA: linoleic, oleic, and palmitic acid. Secondary LFFA derived from this set, as well as their CoA derivatives and synthetic analogs, are effective also in promoting longevity and delaying the onset of age associated disorders. In addition, interventions including LFFA and CoA LFFA formulations are described which protect the organism from acute physical stress, tissue damage, and hypoxia, either due to trauma or secondary to surgical procedures.
REFERENCES:
patent: 4752618 (1988-06-01), Mascioli et al.
patent: 4826877 (1989-05-01), Stewart et al.
patent: 4871768 (1989-10-01), Bistrian et al.
patent: 4879312 (1989-11-01), Kamarei et al.
patent: 5043328 (1991-08-01), Weithmann
patent: 5164414 (1992-11-01), Vincent et al.
patent: 5221668 (1993-06-01), Henningfield et al.
patent: 5223285 (1993-06-01), DeMichele et al.
patent: 5231085 (1993-07-01), Alexander et al.
patent: 5260336 (1993-11-01), Forse et al.
patent: 5397701 (1995-03-01), Devadas et al.
patent: 5541225 (1996-07-01), Leaf et al.
patent: 5571689 (1996-11-01), Heuckeroth et al.
patent: 5709863 (1998-01-01), Pageat
patent: 5731346 (1998-03-01), Egberg
patent: 5747533 (1998-05-01), Egberg et al.
patent: 5767156 (1998-06-01), Ferrante
patent: 5780237 (1998-07-01), Bursten et al.
patent: 5871954 (1999-02-01), Heuckeroth et al.
patent: 6034132 (2000-03-01), Remmereit
patent: 6036992 (2000-03-01), Borror et al.
patent: 6054481 (2000-04-01), Pageat
patent: 6077867 (2000-06-01), Pageat
patent: 6169113 (2001-01-01), Pageat
patent: 6365628 (2002-04-01), Berge
patent: 6380253 (2002-04-01), Das
patent: 6384252 (2002-05-01), Pageat
patent: 6395782 (2002-05-01), Cook et al.
patent: 6441036 (2002-08-01), Berge
patent: 2 318 392 (1999-07-01), None
patent: 0071357 (1983-02-01), None
patent: 0635267 (1995-01-01), None
patent: 60-025934 (1985-08-01), None
patent: 03-297364 (1991-12-01), None
patent: 07267864 (1995-10-01), None
patent: WO9312756 (1993-07-01), None
patent: WO 98/16215 (1998-04-01), None
patent: WO 01/17524 (2001-03-01), None
Weindruch, R., “Caloric Restriction and Aging”, Scientific American, 46-52 (1996).
Roth, G., et al.; “Effect of Caloric Modification on Aging Rate in Nonhuman Primates: A Progress Report”, Proceedings of an International Conference sponsored by the American Health Foundation, 193-204 (1988).
Masoro, E., et al.; “Caloric Restriction and Aging in Rats”, Proceedings of an International Conference sponsored by the American Health Foundation, 123-136 (1988).
Weindruch, R.; “Retardation of Aging by Caloric Restriction in Mice”; Proceedings of an International Conference sponsored by the American Health Foundation,109-121 (1988).
Fernandes, G., “Modulation of Immune Functions and Aging by Omega-3 Fatty Acids and/or Calorie Restriction”, Proceedings of an International Conference sponsored by the American Health Foundation, 263-287 (1988).
Tollotson, J., et al.; “Effects of Linoleic acid on mammary tumor cell proliferation are associated with changes in p53 protein expression” International Journal of Oncology, vol. 3, 81-87 (1993).
Johannes, L.; “The Surprising Rise of a Radical Diet: ‘Calorie Restriction’”, The Wall Street Journal, vol. CCXXXIX, A1 & A10 (2002).
Wiersinga, W., et al.; “Inhibition of nuclear T3 binding by fatty acids: dependence on chain length, unsaturated bonds, cis-trans configuration and esterification”, Int. J. Biochem, vol. 3, 269-273 (1990) (Abstract only).
Inoue, A. et al.; “Nuclear Receptor Solubilized Receptor and the Receptor in Cultured Cells”, Eur J Biochem, vol. 183, 565-572 (1989) (Abstract only).
Davis, F. B., et al.; “Action of Long-Chain Fatty Acids in-Vitro on Calcium-Stimulatable Magnesium-Dependent Atpase Activity in Human Red Cell Membranes”, Biochem J, vol. 248, 511-516, (1987) (Abstract only).
Lane, M., et al.; “The Serious Search for an Anti-Aging Pill”, Scientific American, 36-41, (2002).
Liepa, G., et al.; Food restriction as a modulator of age-related changes in serum lipids, The American Physiological Society, vol. 80, 253-257, (1980).
Roth, G., et al., Slowing ageing by caloric restriction, Nature Medicine, vol. 1, 414-415, (1995).
Pande et al, “Protective role of adenine nucleotide translocase in O2-deficient hearts,” American Journal of Physiology—Heart and Circulatory Physiology, 1984, U.S., vol. 16, No. 1, pp. H25-H34.
Database WPI, Section Ch, Week 199207, Derwent Publications Ltd., London, GB, AN 1992-053592, XP002299804 & JP 03 297364 A (Nippon Oils & Fats Co Ltd.), Dec. 27, 1991, Abstract.
Database WPI, Section Ch, Week 198726 Derwent Publications Ltd., London, GB, AN 1987-180578, XP002299805 & JP 62 108844 A (Tsumura Juntendo KK) May 20, 1987, Abstract.
Database WPI, Section Ch, Week 199716 Derwent Publications Ltd., London, GB, AN 1997-119450, XP002299806 & CN 1 080 131 A (Wang R) Jan. 5, 1994, Abstract.
Patent Abstracts of Japan, vol. 2000, No. 11, Jan. 3, 2001, & JP 2000 212058 A (Maruzen Pharmaceut Co Ltd), Aug. 2, 2000, Abstract.
Blonk, MC, et al., “Dose-response effects of fish oil supplementation to healthy volunteers,” Am. J. Clin. Nutr. 52(1); 120-127, 1990.
Bregenard, C. et al., “The influence of free fatty acids on the free fraction of thyroid hormones in serum as estimated by ultrafiltration.” Acta Endocrinol. 116(1):102-107, 1987.
El Boustani, et al., “Enteral absorption in man of eicosapentaenoic acid in different chemical forms,” Lipids 22(10):711-714, 1997.
Goodman, MN, “Starvation in the rat. II. Effect of age and obesity on protein sparing fuel metabolism,” Am J. Physiol. Oct; 239(4):E277-E286, 1980.
Hayashi, T. et al., “Stimulation of cell proliferation and inhibition of gap junctional intercellular communication by linoleic acid,” Cancer Lett. 112(21):103-11, 1997.
Ikeda, I. et al. “Digestion and lymphatic transport of eicosapentaenoic and docosahexaenoic acids given in the form of triacylglycerol, free acid and ethyl ester in rats,” Biochem Biophys Acta 1259(3):297-304, 1995.
Leaf, A. et al., “Do fish oils prevent restenosis after coronary angioplasty?” Circulation 90(5):2248-2257, 1994.
Robinson, D.R. et al., “Suppression of autoimmune disease by dietary n-3 fatty acids,” J. Lipid Res. 34(8): 1435-1444, 1993.
Swarts, HG, et al., “Binding of unsaturated fatty acids to Na+, K(+)-ATPase leading to inhibition and inactivation,” Biochim. Biophys Acta 1024:32-40, 1990.
Tremoli, E. et al., “Prolonged inhibition of platelet aggregation after n-3 fatty acid ethyl ester ingestion by healthy volunteers,” Am J. Clin. Nutr. 61(3):607-613, 1995.
Tillotson, et al. (1993) “Effects of linoleic acid on mammary tumor cell proliferation are associated with changes in p53 protein expression.”International Journal of Oncology3(1): 81-87.
Zusman, Comparative anticancer effects of vaccination and dietary factors on experimentally-induced cancers, In Vivo 12: 675-690 (1998).
Axelrod et al., Stress hormones: Their interaction and regulation, Science, vol. 224, pp. 452-459, May 1984.
Chopra et al., Relationship between serum free fatty acids and thyroid hormone binding inhibitor in nonthyroid illnesses, Journal of Clinical Endocrinology and Metabolism, vol. 60, No. 5, pp. 980-984, 1985.
Kelly et al., Indetification of nak-atpase inhibitors in human plasma as nonesterified fatty acids and lysophospholipids, The Journal of Biological Chemistry, vol. 261, No. 25, Issue of Sep. 5, pp. 11704-11711, 1986.
Rose, D.P., Dietary Fat, Fatty Acids and Breast Cancer, Breast Cancer, Mar. 25, 1997;4(1):7-16.
Miles et al., Glucose and ketone body kinetics in diabetic ketoacidosis, Clinics in Endocrinology and Metabolism, vol. 12, No.
Hunton & Williams LLP
Kwon Brian-Yong S
LandOfFree
Therapeutic intervention to mimic the effect of caloric... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Therapeutic intervention to mimic the effect of caloric..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Therapeutic intervention to mimic the effect of caloric... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3994685